Envestnet Portfolio Solutions, Inc. Charles River Laboratories International, Inc. Transaction History
Envestnet Portfolio Solutions, Inc.
- $23.7 Billion
- Q1 2025
A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 4,679 shares of CRL stock, worth $555,022. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,679
Previous 7,203
35.04%
Holding current value
$555,022
Previous $1.33 Million
47.03%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CRL
# of Institutions
697Shares Held
50.4MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$731 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$604 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$259 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$214 Million0.79% of portfolio
-
Allspring Global Investments Holdings, LLC1.77MShares$211 Million0.5% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $6.03B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...